Kava-Based Supplement.

Melatonin acts on MT1 and MT2 receptors to shift circadian timing while kavalactones modulate GABA-A signalling. In a finished sleep supplement the two are routinely combined and their sedating effects add. Next-morning residual sedation is the practical consequence to plan around.

L-theanine and kava are named among the agents surveyed in reviews of herbal and natural supplements used for sleep. They act by different routes, theanine on glutamatergic tone and cortical alpha activity, kavalactones on GABA-A modulation. A review naming both is not a trial of the pair.

Magnesium sits in the NMDA channel pore in a voltage-dependent block that damps excitatory transmission, a different lever from GABA-A modulation. Finished evening formulas commonly stack the two. The additive subjective effect is a formulation expectation rather than a trial result.

Glycine acts as an inhibitory neurotransmitter in the brainstem and spinal cord and has been studied for sleep onset in its own right. Combined with a GABA-A modulator, inhibitory tone stacks. Both frequently appear in the same finished evening product.

Kavalactones amplify the GABA-A response rather than opening the channel themselves, so they need endogenous GABA present to do anything. Supplemental GABA crosses the blood-brain barrier poorly, which limits how much of the pairing is central. The receptor relationship is established even where the supplemental route is not.

5-HTP bypasses tryptophan hydroxylase and raises serotonin synthesis directly, a separate route from GABA-A modulation. Sleep and calm formulas stack them and the sedating effect adds. Anyone taking a serotonergic medicine should not add 5-HTP without medical advice.

Caffeine raises arousal by blocking adenosine receptors, which pulls against the calming action of a kava preparation. The two do not cancel cleanly because they act on unrelated systems. Separating them by several hours is the practical response.

Kavalactones are poorly water soluble and need a lipid phase to disperse, which is why finished liquids and soft gels use a triglyceride carrier. An MCT vehicle keeps the lactones available for micellar uptake. This is formulation chemistry, not a change in receptor activity.

Phospholipid emulsifiers break a lipophilic extract into fine droplets that mix into bile micelles more readily. Powder and liquid kava formats use lecithin for exactly this reason. It affects dispersion rather than pharmacology.

Piperine slows both oxidative clearance and glucuronidation, the two routes that handle kavalactones. Adding it to a finished kava product raises exposure by an amount that is not predictable from the label. This belongs in the caution column rather than the benefit column.

Silymarin has documented effects on several CYP isoforms and on glucuronidation, so it changes the exposure of anything cleared by those routes. Finished products sometimes pair the two on a hepatic-support rationale. The enzyme interaction is the established part; the pairing's benefit is not.

High-dose green tea extract has its own documented hepatic tolerability record, with COMT and UGT genotype identified as modifiers of how it is handled. Stacking two concentrated botanical extracts that both load hepatic conjugation is a combined-load flag rather than a formulation idea. This says nothing about either extract taken alone at ordinary intakes.

Ashwagandha and kava sit together in many finished calm and sleep formulas and both carry sedating potential, so the subjective effect adds. A recent pooled safety evaluation of Withania somnifera is one of the sources naming supplement combinations in this space. Stacking two botanicals does not average their individual profiles.

Valerian is the component most often placed beside kava in finished sleep formulations and both are named across reviews of supplements used for sleep. The sedating effect adds. Reviews naming both are not trials of the combination.

Hops appears alongside kava and valerian in traditional and modern sleep blends. The rationale is formulation convention plus additive subjective sedation. No trial isolates the pair.

Concentrated botanical extracts with residual solvent activity and low water activity requirements sit awkwardly beside live organisms in one capsule. Formulators generally separate the two rather than co-blend them. This is a manufacturing consideration and not a claim about either ingredient in the body.